Geoffrey Greene to Ovarian Neoplasms
This is a "connection" page, showing publications Geoffrey Greene has written about Ovarian Neoplasms.
Connection Strength
0.159
-
The effects of 17ß-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis. Gynecol Oncol. 2012 Jan; 124(1):134-41.
Score: 0.064
-
Monoclonal antibody recognition of multiple forms of estrogen receptor tagged with [125I]methoxy-iodovinyl estradiol in ovarian carcinomas. J Clin Endocrinol Metab. 1985 Sep; 61(3):412-7.
Score: 0.042
-
Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays. Lab Invest. 1985 Sep; 53(3):349-61.
Score: 0.042
-
Estrogen receptor localization in formalin-fixed, paraffin-embedded endometrium and endometriotic tissues. Int J Gynecol Pathol. 1987; 6(2):140-51.
Score: 0.012